Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Better Plant Sciences Inc C.PLNT.X

Better Plant Sciences Inc. is a Canada-based company. The Company is reviewing potential new business opportunities and acquisitions.

CSE:PLNT.X - Post Discussion

Better Plant Sciences Inc > SIGNS PSILOCYBIN SUPPLY AGREEMENT FOR CLINICAL TRIALS
View:
Post by Viralstocks1 on Sep 30, 2020 1:58pm

SIGNS PSILOCYBIN SUPPLY AGREEMENT FOR CLINICAL TRIALS

News Release (29-09-20): Better Plant Sciences Inc. (CSE: PLNT) (OTCQB: VEGGF) BETTER PLANT SCIENCES SUBSIDIARY NEONMIND SIGNS PSILOCYBIN SUPPLY AGREEMENT FOR CLINICAL TRIALS.
READ HERE: https://betterplantsciences.com/press-release/better-plant-sciences-subsidiary-neonmind-signs-psilocybin-supply-agreement-for-clinical-trials/
Comment by Bewise911 on Oct 03, 2020 10:15am
stock is dead, no more interest on this board or FB.  Too bad they ran it to the ground.  Company also advising for HEY which is at 2 cents.  who would go to them for any advice.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities